Asian age-related macular degeneration: from basic science research perspective.


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
01 2019
Historique:
received: 31 05 2018
accepted: 08 08 2018
revised: 07 08 2018
pubmed: 14 10 2018
medline: 18 5 2019
entrez: 14 10 2018
Statut: ppublish

Résumé

In Asian populations, polypoidal choroidal vasculopathy (PCV), a distinct phenotype of neovascular age-related macular degeneration (AMD), is more prevalent than Caucasians. Recently, there has been significant focus on how PCV differs from typical AMD. Although typical AMD and PCV share a variety of mechanisms by which abnormal angiogenic process occurs at the retinochoroidal interface, PCV has different clinical characteristics such as aneurysm-like dilation at the terminal of choroidal neovascular membranes, less frequent drusen and inner choroidal degeneration due to the thickened choroid. Recent studies support an important role for inflammation, angiogenesis molecules and lipid metabolism in the pathogenesis of neovascular AMD. Furthermore, although less attention has been paid to the role of the choroid in AMD, accumulating evidence suggests that the choriocapillaris and choroid also play a pivotal role in drusenogenesis, typical AMD and PCV. This review discusses the basic pathogenic mechanisms of AMD and explores the difference between typical AMD and PCV. 摘要: 息肉状脉络膜血管病变 (PCV) 是新生血管性年龄相关性黄斑变性 (AMD) 的一种特殊表型, 好发于亚洲人群, 较高加索人更为常见。近年来研究集中关注于PCV与典型AMD的不同之处。尽管典型AMD和PCV在视网膜脉络膜交界面异常血管生成的过程中具有多种相似的发病机制, 但PCV具有不同的临床特征, 如脉络膜新生血管末端瘤样扩张, 由脉络膜肥厚引起的内层脉络膜变性, 较少见玻璃膜疣等。最新研究提出, 炎症、血管生成因子和脂类代谢均在新生血管性AMD的发生中起到重要作用。此外, 虽然研究较少关注脉络膜在AMD中的作用, 但是大量证据表明脉络膜毛细血管和脉络膜在典型AMD和PCV玻璃膜疣发生中起到关键作用。本综述讨论了AMD的基本发病机制, 探讨了典型AMD和PCV之间的差异。.

Autres résumés

Type: Publisher (chi)
摘要: 息肉状脉络膜血管病变 (PCV) 是新生血管性年龄相关性黄斑变性 (AMD) 的一种特殊表型, 好发于亚洲人群, 较高加索人更为常见。近年来研究集中关注于PCV与典型AMD的不同之处。尽管典型AMD和PCV在视网膜脉络膜交界面异常血管生成的过程中具有多种相似的发病机制, 但PCV具有不同的临床特征, 如脉络膜新生血管末端瘤样扩张, 由脉络膜肥厚引起的内层脉络膜变性, 较少见玻璃膜疣等。最新研究提出, 炎症、血管生成因子和脂类代谢均在新生血管性AMD的发生中起到重要作用。此外, 虽然研究较少关注脉络膜在AMD中的作用, 但是大量证据表明脉络膜毛细血管和脉络膜在典型AMD和PCV玻璃膜疣发生中起到关键作用。本综述讨论了AMD的基本发病机制, 探讨了典型AMD和PCV之间的差异。.

Identifiants

pubmed: 30315261
doi: 10.1038/s41433-018-0225-x
pii: 10.1038/s41433-018-0225-x
pmc: PMC6328602
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

34-49

Références

Cell. 2012 May 11;149(4):847-59
pubmed: 22541070
Ophthalmol Retina. 2018 Apr;2(4):295-305
pubmed: 31047238
Retina. 2016 Mar;36(3):499-516
pubmed: 26335436
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17456-61
pubmed: 17079491
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16651-6
pubmed: 17921253
Sci Rep. 2015 Oct 28;5:15702
pubmed: 26507897
Invest Ophthalmol Vis Sci. 2014 Sep 09;55(10):6514-23
pubmed: 25205867
Retina. 2018 Oct;38(10):1984-1992
pubmed: 29384997
EBioMedicine. 2018 Jan;27:258-274
pubmed: 29269042
Prog Retin Eye Res. 2010 Mar;29(2):144-68
pubmed: 20044062
Prog Retin Eye Res. 2017 Sep;60:201-218
pubmed: 28336424
Am J Ophthalmol. 2010 Jul;150(1):40-47.e2
pubmed: 20493466
Mol Cell Biol. 2009 Aug;29(15):4177-87
pubmed: 19470753
Retina. 2013 Apr;33(4):686-716
pubmed: 23455233
Br J Ophthalmol. 2011 Sep;95(9):1323-30
pubmed: 21633121
Ophthalmology. 2017 Aug;124(8):1165-1174
pubmed: 28456421
Nat Genet. 2016 Feb;48(2):134-43
pubmed: 26691988
Ophthalmology. 2009 Dec;116(12):2400-6
pubmed: 19815291
Ophthalmology. 2010 Oct;117(10):1989-95
pubmed: 20888482
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11282-7
pubmed: 16844785
Cell Mol Life Sci. 2017 Dec;74(24):4561-4572
pubmed: 28726057
Ophthalmology. 2011 May;118(5):853-9
pubmed: 21095010
Aging (Albany NY). 2010 Dec;2(12):981-9
pubmed: 21098885
Am J Pathol. 1995 Sep;147(3):642-53
pubmed: 7545873
Prog Retin Eye Res. 2010 Mar;29(2):95-112
pubmed: 19961953
Ophthalmology. 2016 Oct;123(10):2066-76
pubmed: 27506483
PLoS One. 2011;6(8):e22959
pubmed: 21829675
Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2035-42
pubmed: 10892840
J Hum Genet. 2017 Dec;62(12):1049-1055
pubmed: 28835638
J Cell Physiol. 2002 Apr;191(1):116-24
pubmed: 11920687
Am J Ophthalmol. 2007 Jul;144(1):15-22
pubmed: 17509509
Sci Rep. 2016 Jun 24;6:28639
pubmed: 27338780
Br J Ophthalmol. 2006 May;90(5):616-20
pubmed: 16622093
Invest Ophthalmol Vis Sci. 1994 May;35(6):2857-64
pubmed: 8188481
Br J Ophthalmol. 1993 Aug;77(8):515-24
pubmed: 8025051
Exp Eye Res. 2016 Jun;147:138-143
pubmed: 27181225
Br J Ophthalmol. 2002 Oct;86(10):1093-8
pubmed: 12234885
Nat Med. 2016 Apr;22(4):439-45
pubmed: 26974308
Exp Eye Res. 2017 Dec;165:65-77
pubmed: 28943268
Trends Mol Med. 2016 Aug;22(8):656-670
pubmed: 27423265
PLoS One. 2016 Aug 17;11(8):e0160985
pubmed: 27532664
Arch Ophthalmol. 1994 Mar;112(3):402-6
pubmed: 8129668
Sci Rep. 2018 Jan 11;8(1):461
pubmed: 29323137
Am J Pathol. 2012 Oct;181(4):1464-72
pubmed: 22841816
Arch Ophthalmol. 1989 Nov;107(11):1654-8
pubmed: 2818288
Am J Ophthalmol. 1998 Jan;125(1):71-80
pubmed: 9437316
Nat Commun. 2015 Jan 28;6:6063
pubmed: 25629512
Am J Pathol. 2017 Dec;187(12):2841-2857
pubmed: 28941979
Arch Ophthalmol. 1963 Feb;69:220-30
pubmed: 13959793
Invest Ophthalmol Vis Sci. 2012 May 17;53(6):2921-7
pubmed: 22447858
Retina. 2017 Feb;37(2):199-221
pubmed: 27749784
Nat Genet. 2016 Jun;48(6):640-7
pubmed: 27089177
Am J Pathol. 2014 Nov;184(11):3142-53
pubmed: 25204844
Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11900-5
pubmed: 16079201
Am J Ophthalmol. 2008 Jul;146(1):96-101
pubmed: 18439567
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5878-87
pubmed: 20538999
Am J Ophthalmol. 2015 Apr;159(4):634-43
pubmed: 25528955
Br J Ophthalmol. 2010 Jul;94(7):918-25
pubmed: 19965817
Mol Vis. 2017 Jun 14;23:318-333
pubmed: 28659708
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4729-37
pubmed: 18586873
Graefes Arch Clin Exp Ophthalmol. 2013 Dec;251(12):1-9
pubmed: 23677486
Hum Mol Genet. 2016 Nov 15;25(22):5027-5034
pubmed: 28173125
Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5336-42
pubmed: 20484595
Retina. 2018 Sep;38(9):1652-1667
pubmed: 29135799
Invest Ophthalmol Vis Sci. 2013 May 01;54(5):3621-31
pubmed: 23633664
Prog Retin Eye Res. 2001 Nov;20(6):705-32
pubmed: 11587915
Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14578-83
pubmed: 21844367
Prog Retin Eye Res. 2009 Nov;28(6):393-422
pubmed: 19698799
J Am Chem Soc. 2016 Aug 3;138(30):9473-8
pubmed: 27379525
J Stem Cells. 2015;10(3):193-203
pubmed: 27125063
Matrix Biol. 2018 Sep;70:84-101
pubmed: 29572155
Invest Ophthalmol Vis Sci. 2005 Mar;46(3):1033-8
pubmed: 15728562
J Biol Chem. 2018 Mar 16;293(11):4071-4084
pubmed: 29414786
Sci Rep. 2017 Dec 21;7(1):17995
pubmed: 29269789
J Biol Chem. 2012 Jan 6;287(2):1520-6
pubmed: 22049084
Ophthalmology. 2010 May;117(5):928-38
pubmed: 20132989
Lancet Glob Health. 2014 Feb;2(2):e106-16
pubmed: 25104651
Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4407-20
pubmed: 17898259
Br J Ophthalmol. 1976 May;60(5):324-41
pubmed: 952802
Sci Rep. 2017 Jan 25;7:41386
pubmed: 28120909
Retina. 2018 Apr;38(4):708-716
pubmed: 28505013
Cell Stem Cell. 2017 May 4;20(5):635-647.e7
pubmed: 28132833
Am J Ophthalmol. 2002 Sep;134(3):411-31
pubmed: 12208254
Mol Cell Biol. 2012 Nov;32(21):4482-92
pubmed: 22949504
Ophthalmology. 1993 Oct;100(10):1519-35
pubmed: 7692366
Mol Aspects Med. 2012 Aug;33(4):295-317
pubmed: 22542780
Nat Chem Biol. 2015 Nov;11(11):862-9
pubmed: 26436840
Surv Ophthalmol. 1995 Mar-Apr;39(5):367-74
pubmed: 7604360
Br J Ophthalmol. 2016 May;100(5):720-6
pubmed: 26931413
Prog Retin Eye Res. 2014 Jul;41:64-89
pubmed: 24704580
Ophthalmology. 1990 Feb;97(2):171-8
pubmed: 1691475
Prog Lipid Res. 2018 Jan;69:21-32
pubmed: 29269048
EBioMedicine. 2016 Feb 04;5:198-203
pubmed: 27077128
Nat Med. 2018 Jan;24(1):50-61
pubmed: 29176737
Prog Retin Eye Res. 2016 May;52:130-55
pubmed: 26478514
Invest Ophthalmol Vis Sci. 1999 Mar;40(3):775-9
pubmed: 10067983
Nat Med. 2012 May;18(5):791-8
pubmed: 22484808
Curr Eye Res. 2018 Jan;43(1):135-146
pubmed: 28972410
Cell Metab. 2013 Apr 2;17(4):549-61
pubmed: 23562078

Auteurs

Yasuo Yanagi (Y)

Singapore National Eye Centre, Singapore, Singapore. yasuo.yanagi@snec.com.sg.
Singapore Eye Research Institute, Singapore, Singapore. yasuo.yanagi@snec.com.sg.
Duke-NUS Medical School, Singapore, Singapore. yasuo.yanagi@snec.com.sg.

Valencia Hui Xian Foo (VHX)

Singapore National Eye Centre, Singapore, Singapore.
Singapore Eye Research Institute, Singapore, Singapore.

Akitoshi Yoshida (A)

Department of Ophthalmology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH